Gene: TRIP10
Official Full Name: thyroid hormone receptor interactor 10provided by HGNC
Gene Summary: Enables identical protein binding activity. Predicted to be involved in actin cytoskeleton organization and signal transduction. Located in nucleoplasm. Biomarker of Huntington's disease. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33335 | TRIP10 Knockout cell line (HeLa) | Human | TRIP10 | 1:3~1:6 | Negative | Online Inquiry |
KO33336 | TRIP10 Knockout cell line (HCT 116) | Human | TRIP10 | 1:2~1:4 | Negative | Online Inquiry |
KO33337 | TRIP10 Knockout cell line (HEK293) | Human | TRIP10 | 1:3~1:6 | Negative | Online Inquiry |
KO33338 | TRIP10 Knockout cell line (A549) | Human | TRIP10 | 1:3~1:4 | Negative | Online Inquiry |
TRIP10 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack the expression of the TRIP10 (thyroid hormone receptor-interacting protein 10) gene. This product enables researchers to investigate the biological functions associated with TRIP10 and its role in various cellular processes, including cell growth, metabolism, and signaling pathways. By employing these knockout cell lines, scientists can elucidate the effects of TRIP10 deficiency on cellular mechanisms, providing insights into its potential implications in diseases such as cancer, metabolic disorders, and neurodegenerative diseases.
The primary mechanism by which TRIP10 Gene Knockout Cell Lines operate involves the genetic inactivation of the TRIP10 gene, achieved through techniques such as CRISPR-Cas9 or homologous recombination. This knockout allows for the observation of phenotypic changes and altered cellular behavior in response to the loss of this gene, thereby supporting an enhanced understanding of its biological roles. Researchers can leverage these cell lines to conduct functional assays, drug testing, and high-throughput screening.
Scientifically, these knockout cell lines hold significant importance in both basic research and clinical applications. They serve as vital tools for dissecting the molecular pathways influenced by TRIP10 and aid in the development of targeted therapies for TRIP10-related pathologies. Furthermore, these cell lines have the potential to contribute to the advancement of personalized medicine strategies.
What sets TRIP10 Gene Knockout Cell Lines apart from alternative products is the precision and customization that they offer. These lines are rigorously validated, ensuring that researchers receive reliable and reproducible data. The availability of knockout cell lines tailored to specific needs accelerates research timelines, enabling scientists to quickly gather actionable insights.
For researchers and clinicians alike, TRIP10 Gene Knockout Cell Lines represent a powerful solution to unlock the complexities of gene function and facilitate innovative therapeutic strategies. Our company, with its commitment to advancing genetic research and providing high-quality biological products, stands ready to support your endeavors with expert guidance and exceptional product offerings.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.